当前位置: 首页 > 期刊 > 《医学信息》 > 20208
编号:13503108
甲巯咪唑对初诊Graves病患者血清相关细胞因子 及microRNAs水平的影响(4)
http://www.100md.com 2020年2月26日 《医学信息》 20208
     [4]Qin Q,Wang X,Yan N,et al.Aberrant expression of miRNA and mRNAs in lesioned tissues of Graves'disease[J].Cell Physiol Biochem,2015,35(5):1934-1942.

    [5]Merrill SJ,Minucci SB.Thyroid autoimmunity: an interplay of factors[M].Vitamins and hormones.Academic Press,2018(106):129-145.

    [6]操伟庆,季榕.白细胞介素17及其与多种疾病的关系[J].现代临床医学,2017,43(4):246-250.

    [7]Czarnywojtek A,Owecki M,Zgorzalewicz-Stachowiak M,et al.The Role of Serum C-Reactive Protein Measured by High-Sensitive Method in Thyroid Disease[J].Archivum Immunologiae Et Therapiae Experimentalis,2014,62(6):501-509.

    [8]Hiratsuka I,Yamada H,Munetsuna E,et al.Circulating microRNAs in Graves' disease in relation to clinical activity[J].Thyroid,2016,26(10):1431-1440.

    [9]Yamada H,Itoh M,Hiratsuka I,et al.Circulating micro RNA s in autoimmune thyroid diseases[J].Clinical Endocrinology,2014,81(2):276-281.

    [10]Chen X,Huang F,Qi Y,et al.Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves’disease[J].Journal of Translational Medicine,2018,16(1)188.

    [11]Zheng L,Zhuang C,Wang X,et al.Serum miR‐146a,miR‐155,and miR‐210 as potential markers of Graves’disease[J].Journal of Clinical Laboratory Analysis,2018,32(2):e22266.

    收稿日期:2020-03-03;修回日期:2020-03-17

    編辑/李国苗, 百拇医药(姜丽莉 王静 李振凤 周齐 栾雪静 任新雯)
上一页1 2 3 4